Pharming Group Current Ratio 2013-2021 | PHGUF

Pharming Group current ratio from 2013 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Pharming Group Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.25B $0.05B 5.25
2021-03-31 $0.26B $0.07B 3.55
2020-12-31 $0.26B $0.08B 3.43
2020-03-31 $0.20B $0.05B 4.03
2019-03-31 $0.12B $0.07B 1.63
2018-03-31 $0.12B $0.07B 1.60
2017-03-31 $0.07B $0.07B 1.07
2016-03-31 $0.05B $0.02B 3.01
2015-03-31 $0.05B $0.02B 3.37
2014-03-31 $0.04B $0.02B 2.01
2013-03-31 $0.03B $0.03B 0.95
2012-12-31 $0.01B $0.01B 0.94
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.583B $0.212B
Pharming Group NV develops innovative therapeutics for the treatment of genetic disorders, specialty products for surgical indications and nutritional products. The advanced technologies of the Company include innovative and validated platforms for the production of protein therapeutics, technology and processes for the purification and formulation of its products. Its primary product Ruconest (R) is a recombinant human C1 inhibitor approved for the treatment of angioedema attacks in patients with hereditary angioedema in the European Union countries, Norway, Iceland and Liechtenstein. Pharming Group NV is headquartered in Leiden, the Netherlands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76